Lenis-Ballesteros Viviana, Hincapié-Palacio Doracelly, Ochoa Jesús, Ospina Marta, Buitrago Seti
Epidemiology Research Group at "Héctor Abad Gómez" National Faculty of Public Health at University of Antioquia, Medellín, Colombia.
Public Health Surveillance team at The Sectional Secretariat of Health and Social Protection of Antioquia, Medellín, Colombia.
IJID Reg. 2025 May 7;15:100662. doi: 10.1016/j.ijregi.2025.100662. eCollection 2025 Jun.
To describe the distribution of immunoglobulin (Ig) G antibodies against varicella by sociodemographic characteristics during the period before vaccination in Medellín, Antioquia, Colombia.
A population seroprevalence based on a previous study carried out in men and women aged 6-64 years, residing in the urban and rural zone of Medellín, Antioquia, Colombia in 2009. A probability sample of 2124 individuals was selected using a multistage sampling design. IgG antibodies against varicella zoster virus were determined in human serum/plasma by an enzyme-linked immunosorbent assay test. Global seroprevalence levels were calculated, considering a sample expansion factor, allowing inference to the population. Antibody distribution was explored worldwide by sex and zone of residence, using finite mixture models.
Global seropositivity was 85.9% (95% confidence interval [CI]: 82.9-88.5) using the manufacturer's cutoff and 81.5% (95% CI: 78.0-88.5) using the complete data from antibody distribution. Significant seronegativity was detected in the group from 6 to 17 years of age of 20.6% (95% CI: 14.8-27.9), without differences by sex and zone of residence.
The seronegativity in the 6-17 age group shows the need to periodically monitor antibody prevalence in children and young people to guide new vaccination and transmission prevention strategies.
描述在哥伦比亚安蒂奥基亚省麦德林市疫苗接种前,按社会人口学特征划分的抗水痘免疫球蛋白(Ig)G抗体分布情况。
基于2009年在哥伦比亚安蒂奥基亚省麦德林市城乡地区居住的6 - 64岁男女中进行的一项先前研究进行人群血清流行率调查。采用多阶段抽样设计选取了2124名个体的概率样本。通过酶联免疫吸附测定法检测人血清/血浆中抗水痘带状疱疹病毒的IgG抗体。计算总体血清流行率水平,考虑样本扩展因子,以便推断总体情况。使用有限混合模型按性别和居住区域探讨全球抗体分布情况。
使用制造商的临界值时,总体血清阳性率为85.9%(95%置信区间[CI]:82.9 - 88.5),使用抗体分布的完整数据时为81.5%(95% CI:78.0 - 88.5)。在6至17岁年龄组中检测到显著的血清阴性率为20.6%(95% CI:14.8 - 27.9),在性别和居住区域方面无差异。
6 - 17岁年龄组的血清阴性表明有必要定期监测儿童和青少年的抗体流行率,以指导新的疫苗接种和传播预防策略。